Frans Maas

1.3k total citations
14 papers, 895 citations indexed

About

Frans Maas is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Frans Maas has authored 14 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Hematology and 6 papers in Oncology. Recurrent topics in Frans Maas's work include Hematopoietic Stem Cell Transplantation (8 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (7 papers). Frans Maas is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (7 papers). Frans Maas collaborates with scholars based in Netherlands, United States and Poland. Frans Maas's co-authors include Harry Dolstra, Nicolaas Schaap, Willemijn Hobo, Robbert van der Voort, Hanny Fredrix, Theo M. de Witte, J.H. Frederik Falkenburg, Théo de Witte, Michel G.D. Kester and Wieger J. Norde and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Frans Maas

14 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frans Maas Netherlands 13 710 456 291 221 60 14 895
Riyan Chen Canada 13 691 1.0× 172 0.4× 257 0.9× 200 0.9× 95 1.6× 18 936
Françoise Mallet France 12 646 0.9× 343 0.8× 302 1.0× 201 0.9× 18 0.3× 17 905
Sascha Haubner Germany 9 263 0.4× 393 0.9× 197 0.7× 207 0.9× 97 1.6× 16 614
Corina Buechele United States 9 366 0.5× 250 0.5× 187 0.6× 204 0.9× 33 0.6× 15 601
A Choudhury Sweden 13 511 0.7× 299 0.7× 81 0.3× 194 0.9× 34 0.6× 18 689
Stefanie Lindner Germany 10 307 0.4× 266 0.6× 175 0.6× 396 1.8× 22 0.4× 17 754
Anthony G. Brickner United States 13 428 0.6× 100 0.2× 207 0.7× 190 0.9× 69 1.1× 17 604
Annalisa Rossini Italy 5 197 0.3× 192 0.4× 180 0.6× 226 1.0× 40 0.7× 8 499
Olivia Simma Austria 11 410 0.6× 262 0.6× 121 0.4× 145 0.7× 17 0.3× 11 622
Huaijian Guo Canada 8 492 0.7× 236 0.5× 148 0.5× 166 0.8× 13 0.2× 11 661

Countries citing papers authored by Frans Maas

Since Specialization
Citations

This map shows the geographic impact of Frans Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frans Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frans Maas more than expected).

Fields of papers citing papers by Frans Maas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frans Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frans Maas. The network helps show where Frans Maas may publish in the future.

Co-authorship network of co-authors of Frans Maas

This figure shows the co-authorship network connecting the top 25 collaborators of Frans Maas. A scholar is included among the top collaborators of Frans Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frans Maas. Frans Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Norde, Wieger J., Rob Woestenenk, Ruochen Wang, et al.. (2017). Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(4). 666–677. 38 indexed citations
2.
Cany, Jeannette, Mieke W.H. Roeven, Janneke S. Hoogstad‐van Evert, et al.. (2017). Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice. Blood. 131(2). 202–214. 48 indexed citations
3.
Roeven, Mieke W.H., Soley Thordardottir, Frans Maas, et al.. (2015). The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34 + Hematopoietic Stem and Progenitor Cells. Stem Cells and Development. 24(24). 2886–2898. 31 indexed citations
4.
Waart, Anniek B. van der, Frans Maas, Cynthia S. M. Kramer, et al.. (2014). Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 124(23). 3490–3500. 94 indexed citations
5.
Hobo, Willemijn, Frans Maas, Hanny Fredrix, et al.. (2013). Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients. Cancer Immunology Immunotherapy. 62(8). 1381–1392. 61 indexed citations
6.
Voort, Robbert van der, Thomas J. H. Volman, Viviènne Verweij, et al.. (2012). Homing Characteristics of Donor T Cells after Experimental Allogeneic Bone Marrow Transplantation and Posttransplantation Therapy for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 19(3). 378–386. 10 indexed citations
7.
Hobo, Willemijn, Wieger J. Norde, Nicolaas Schaap, et al.. (2012). B and T Lymphocyte Attenuator Mediates Inhibition of Tumor-Reactive CD8+ T Cells in Patients After Allogeneic Stem Cell Transplantation. The Journal of Immunology. 189(1). 39–49. 56 indexed citations
8.
Norde, Wieger J., Frans Maas, Willemijn Hobo, et al.. (2011). PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation. Cancer Research. 71(15). 5111–5122. 126 indexed citations
9.
Hobo, Willemijn, Frans Maas, Théo de Witte, et al.. (2010). siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen–specific CD8+ T cells. Blood. 116(22). 4501–4511. 119 indexed citations
11.
Norde, Wieger J., Frans Maas, Hanny Fredrix, et al.. (2008). Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1–reactive cytotoxic T cells. Blood. 113(10). 2312–2323. 38 indexed citations
12.
Wilke, Martina, Harry Dolstra, Frans Maas, et al.. (2003). Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies. The Hematology Journal. 4(5). 315–320. 32 indexed citations
13.
Dolstra, Harry, Hanny Fredrix, A. Balas, et al.. (2002). Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. European Journal of Immunology. 32(10). 2748–2758. 45 indexed citations
14.
Dolstra, Harry, Hanny Fredrix, Frans Maas, et al.. (1999). A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia. The Journal of Experimental Medicine. 189(2). 301–308. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026